↓ Skip to main content

Tocilizumab improves clinical outcome in patients with active corticosteroid-resistant moderate-to-severe Graves’ orbitopathy: an observational study

Overview of attention for article published in Frontiers in endocrinology, June 2023
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Good Attention Score compared to outputs of the same age and source (75th percentile)

Mentioned by

twitter
3 X users

Citations

dimensions_citation
2 Dimensions

Readers on

mendeley
14 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Tocilizumab improves clinical outcome in patients with active corticosteroid-resistant moderate-to-severe Graves’ orbitopathy: an observational study
Published in
Frontiers in endocrinology, June 2023
DOI 10.3389/fendo.2023.1186105
Pubmed ID
Authors

Georgios Boutzios, Sofia Chatzi, Andreas V Goules, Areti Mina, George C Charonis, Panayiotis G Vlachoyiannopoulos, Athanasios G Tzioufas

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 14 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 14 100%

Demographic breakdown

Readers by professional status Count As %
Other 2 14%
Professor 1 7%
Professor > Associate Professor 1 7%
Student > Bachelor 1 7%
Student > Doctoral Student 1 7%
Other 0 0%
Unknown 8 57%
Readers by discipline Count As %
Medicine and Dentistry 3 21%
Biochemistry, Genetics and Molecular Biology 2 14%
Unspecified 1 7%
Unknown 8 57%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 10 August 2023.
All research outputs
#16,607,632
of 26,180,352 outputs
Outputs from Frontiers in endocrinology
#4,160
of 13,379 outputs
Outputs of similar age
#194,269
of 386,749 outputs
Outputs of similar age from Frontiers in endocrinology
#167
of 812 outputs
Altmetric has tracked 26,180,352 research outputs across all sources so far. This one is in the 34th percentile – i.e., 34% of other outputs scored the same or lower than it.
So far Altmetric has tracked 13,379 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.2. This one has gotten more attention than average, scoring higher than 66% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 386,749 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 46th percentile – i.e., 46% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 812 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 75% of its contemporaries.